13 Facts About Sadaf Farooqi

Sadaf Farooqi's group have demonstrated that the central leptin-melanocortin axis plays a critical role in the regulation of human food intake.

Sadaf Farooqi's research has proven that mutations in the KSR2 gene are associated with insulin resistance and that genetic variation in the fat mass and obesity-associated protein is associated with diminished hunger.

Sadaf Farooqi's research has been funded by the Wellcome Trust, Addenbrooke's Charitable Trust and the Framework Programmes for Research and Technological Development from the European Union.

Sadaf Farooqi was elected a Fellow of the Royal Society in 2021.

Sadaf Farooqi was elected a Fellow of the Academy of Medical Sciences in 2013.

Sadaf Farooqi has fundamentally altered our understanding of human obesity.

Sadaf Farooqi's work was key to the discovery of the first mutations that cause human obesity, defining and characterising a range of previously undescribed genetic obesity syndromes, and establishing that the principal driver of obesity in these monogenic syndromes was a failure of the central control of appetite and satiety.

Sadaf Farooqi has been greatly committed to the translation of her research into patient benefit and has helped to change clinical attitudes and diagnostic practice world-wide.

Obesity is one of the major public health threats facing the international community and Sadaf Farooqi's research has been critical in bringing real biological insights where these were previously lacking.

Sadaf Farooqi was interviewed by Jim Al-Khalili on The Life Scientific, first broadcast on BBC Radio 4 in 2017.

Sadaf Farooqi was awarded the American Diabetes Association's Outstanding Scientific Achievement Award in 2019.

In 1997, Sadaf Farooqi noticed that two children she was studying lacked the hormone leptin.

Sadaf Farooqi tells Jim how she discovered ten rare genetic disorders that cause severe childhood obesity and what this means for the rest of us.